Increasing Access to Erectile Dysfunction Treatment via Pharmacies to Improve Healthcare Provider Visits and Quality of Life: Results from a Prospective Real-World Observational Study in the United Kingdom.

The Medicines and Healthcare Products Regulatory Agency in the United Kingdom (UK) formally reclassified sildenafil citrate 50 mg tablets as a pharmacy medicine (sildenafil-P) in 2017 for adult men with erectile dysfunction (ED).